Associations between regional adipose tissue distribution and skeletal muscle bioenergetics in older men and women - Brennan, Andrea M.; Coen, Paul M.; Mau, Theresa; Hetherington-Rauth, Megan; Toledo, Frederico G.S.; Kershaw, Erin E.; Cawthon, Peggy M.; Kramer, Philip A.; Ramos, Sofhia V.; Newman, Anne B.; Cummings, Steven R.; Forman, Daniel E.; et al. (medRxiv, 2023)
Objective Examine the association of ectopic adipose tissue (AT) with skeletal muscle (SM) mitochondrial bioenergetics in older adults.Methods Cross-sectional data from 829 older adults ≥70 years was used. Total abdominal, subcutaneous, and visceral AT; and thigh muscle fat infiltration (MFI) was quantified by MRI. SM mitochondrial energetics were characterized using in vivo 31P-MRS (ATPmax) and ex vivo high-resolution respirometry (maximal oxidative phosphorylation (OXPHOS)). ActivPal was used to measure PA (step count). Linear regression models adjusted for covariates were applied, with sequential adjustment for BMI and PA.Results Independent of BMI, total abdominal (standardized (Std.) β=-0.21; R2=0.09) and visceral AT (Std. β=-0.16; R2=0.09) were associated with ATPmax (p<0.01), but not after further adjustment for PA (p≥0.05). Visceral AT (Std. β=-0.16; R2=0.25) and thigh MFI (Std. β=-0.11; R2=0.24) were negatively associated with carbohydrate-supported maximal OXPHOS independent of BMI and PA (p<0.05). Total abdominal AT (Std. β=-0.19; R2=0.24) and visceral AT (Std. β=-0.17; R2=0.24) were associated with fatty acid-supported maximal OXPHOS independent of BMI and PA (p<0.05).Conclusions Skeletal MFI and abdominal visceral, but not subcutaneous AT, are inversely associated with SM mitochondrial bioenergetics in older adults independent of BMI. Associations between ectopic AT and in vivo mitochondrial bioenergetics are attenuated by PA.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe Study of Muscle, Mobility and Aging is funded by the National Institute on Aging (NIA) R01AG059416. Study infrastructure support was funded in part by NIA Claude D. Pepper Older American Independence Centers at University of Pittsburgh (P30AG024827), Wake Forest University School of Medicine (P30AG021332), and the Clinical and Translational Science Institute which is funded by the National Center for Advancing Translational Science at Wake Forest University School of Medicine (UL1TR001420). Effort support for intellectual contributions from LMS and EEK provided by R01AG066474.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was approved by the WIRB-Copernicus Group (WCG) Institutional Review Board (WCGIRB, study number 20180764)I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors.